Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.

Pharmaceutical

Orasis Pharmaceuticals

Elad Kedar

Yaron Shimon

Merav Zeide

Ilan Rubin

Paul Smith

Iris Meisner

Ron Neumann

Sharon Amzel-Sasson

Advisory and Board Team

Leadership Team

Clinical and Medical Affairs

Teams at Orasis Pharmaceuticals

Advisory and Board Team

Leadership Team

Clinical and Medical Affairs